CARLSBAD, Calif.--(BUSINESS WIRE)--Life Technologies Corporation (NASDAQ:LIFE) today announced the launch of a new genetic analysis system designed to optimize data quality and deliver increased reliability, performance, quality assurance and ease-of-use specifically for forensic DNA testing laboratories. The Applied Biosystems 3500 Series Genetic Analyzer is the latest advancement in the company’s industry leading line of capillary electrophoresis (CE) DNA sequencing systems, and has been validated to support a specific feature set and workflow for human identification (HID) applications. The company made the announcement at the American Academy of Forensic Sciences 62nd Annual Meeting in Seattle, Washington.
